Locally Advanced or Metastatic Pancreatic Cancer
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AS
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AB ScienceMasitinib
Taiho OncologyS-1
Clinical Trials (2)
Total enrollment: 28 patients across 2 trials
Masitinib Plus Gemcitabine in Pancreatic Cancer
Start: Jul 2014Est. completion: Dec 2020
Phase 3Completed
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Start: Jan 2006Est. completion: Jul 200828 patients
Phase 2Completed
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
4h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
4h ago
Office Administrator
SystImmune
4h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
4h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
4h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
4h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space